Discontinuation of NTBC after liver transplantation in tyrosinemia type 1

被引：0
|
作者：
Kurihara, Kosuke [1 ]
Toyoda, Hidemi [1 ]
Amoano, Keishirou [1 ]
Inoue, Mikihiro [2 ]
Uchida, Keiichi [2 ]
Sakurai, Hiroyuki [3 ]
Hayashi, Akinobu [4 ]
Hirayama, Masahiro [1 ]
机构：
[1] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie, Japan
[2] Mie Univ, Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie, Japan
[3] Mie Univ, Sch Med, Dept Transplant Surg, Tsu, Mie, Japan
[4] Mie Univ, Sch Med, Dept Pathol, Tsu, Mie, Japan
来源：
PEDIATRICS INTERNATIONAL | 2018年 / 60卷 / 11期
关键词：
2-(2-nitro-4-trifluoromethylbenzoyl)-1-3-cyclohexanedione; hereditary tyrosinemia type 1; liver transplantation;
D O I：
10.1111/ped.13697
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1039 / 1041
页数：3
相关论文
共 50 条
  • [1] Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation
    Kehar, Mohit
    Sen Sarma, Moinak
    Seetharaman, Jayendra
    Rivera, Carolina Jimenez
    Chakraborty, Pranesh
    CANADIAN LIVER JOURNAL, 2024, 7 (01): : 54 - 63
  • [2] IMPROVEMENT IN LIVER-FUNCTION AND HISTOLOGY IN TYROSINEMIA TYPE-1 WITH NTBC
    MCKIERNAN, PJ
    PREECE, MA
    GREEN, A
    LINDSTEDT, S
    HOLME, E
    LOCK, EA
    KELLY, DA
    HEPATOLOGY, 1995, 22 (04) : 1076 - 1076
  • [3] REGRESSION OF LIVER NODULES IN TWO PATIENTS WITH TYROSINEMIA TYPE 1 IN TREATMENT WITH NTBC
    Bay, L.
    Eiroa, H. D.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 31 - 32
  • [4] Favorable outcome of hereditary tyrosinemia type 1 induced liver failure with NTBC treatment.
    Barkaoui, E
    Debray, D
    Habès, D
    Ogier, H
    Bernard, O
    ARCHIVES DE PEDIATRIE, 1999, 6 (05): : 540 - 544
  • [5] NTBC therapy for tyrosinemia type 1: How much is enough?
    El-Karaksy, H. K.
    Rashed, M. S.
    El-Sayed, R.
    El-Raziky, M. S.
    El-Koofy, N. M.
    El-Hawary, M. A.
    Al-Dirbashi, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S332 - S332
  • [6] THE NEPHROPATHY OF TYPE-1 TYROSINEMIA AFTER LIVER-TRANSPLANTATION IN CHILDREN
    LAINE, J
    SALO, MK
    KROGERUS, L
    KARKKAINEN, J
    WAHLROOS, O
    HOLMBERG, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 648 - 648
  • [7] SINGLE DOSE NTBC-TREATMENT OF HEREDITARY TYROSINEMIA TYPE 1
    Schlune, A.
    Thimm, E.
    Herebian, D.
    Spiekerkoetter, U.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S81 - S81
  • [8] TYROSINEMIA TYPE 1: EARLY EFFECT OF NTBC ON RENAL TUBULAR FUNCTION
    Maiorana, A. M.
    Emma, F. E.
    Deodato, F. D.
    Boenzi, S. B.
    Martinelli, D. M.
    Rizzo, C. R.
    Dionisi-Vici, C. D. V.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S25 - S25
  • [9] DOES TREATMENT WITH NTBC AFFECT COGNITIVE FUNCTIONING IN TYROSINEMIA TYPE 1?
    van Hasselt, P. M.
    Bendadi, F.
    Visser, G.
    Sinnema, G.
    van Spronsen, F. J.
    de Koning, T. J.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 28 - 28
  • [10] HEREDITARY TYROSINEMIA TYPE I: LIVER TRANSPLANTAION (LT) WITH LIVING DONOR FOR HEPATOCARCINOMA AFTER 7 YEARS OF NTBC
    Barkaoui, E.
    Mannai, S.
    Mestiri, H.
    Boujemaa, K.
    Abbes, S.
    PEDIATRIC RESEARCH, 2010, 68 : 401 - 401
12345